ReviewProstate cancer and prostatic diseases2023

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging.

Hae Lin Cho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.